Barinthus Biotherapeutics Dividend
Dividend criteriumcontroles 0/6
Barinthus Biotherapeutics does not have a record of paying a dividend.
Belangrijke informatie
n/a
Dividendrendement
-1.8%
Terugkoop Rendement
Totaal aandeelhoudersrendement | -1.8% |
Toekomstig dividendrendement | n/a |
Dividendgroei | n/a |
Volgende betaaldatum dividend | n/a |
Ex-dividenddatum | n/a |
Dividend per aandeel | n/a |
Uitbetalingsratio | n/a |
Recente dividendupdates
Geen updates
Recent updates
Is Barinthus Biotherapeutics (NASDAQ:BRNS) In A Good Position To Invest In Growth?
Aug 31Here's Why We're Watching Barinthus Biotherapeutics' (NASDAQ:BRNS) Cash Burn Situation
Apr 05We Think Vaccitech (NASDAQ:VACC) Can Afford To Drive Business Growth
Jul 07Vaccitech's (NASDAQ:VACC) Earnings Are Of Questionable Quality
Nov 17Vaccitech promotes Gemma Brown to CFO
Sep 20Analysts Just Made An Incredible Upgrade To Their Vaccitech plc (NASDAQ:VACC) Forecasts
Aug 15Vaccitech plc Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Aug 13Vaccitech GAAP EPS of $0.41, revenue of $17.06M
Aug 09Growth Investors: Industry Analysts Just Upgraded Their Vaccitech plc (NASDAQ:VACC) Revenue Forecasts By 51%
May 19Vaccitech: Aiming For A Cure In Chronic Hepatitis B
Apr 03Vaccitech: The Next Big Vaccine Trade
Jun 27Vaccitech EPS misses by $0.69, beats on revenue
Jun 14Stabiliteit en groei van betalingen
Dividenden ophalen
Stabiel dividend: Insufficient data to determine if BRNS's dividends per share have been stable in the past.
Groeiend dividend: Insufficient data to determine if BRNS's dividend payments have been increasing.
Dividendrendement versus markt
Barinthus Biotherapeutics Dividendrendement versus markt |
---|
Segment | Dividendrendement |
---|---|
Bedrijf (BRNS) | n/a |
Markt onderkant 25% (US) | 1.5% |
Markt Top 25% (US) | 4.5% |
Gemiddelde industrie (Biotechs) | 2.2% |
Analist prognose (BRNS) (tot 3 jaar) | n/a |
Opmerkelijk dividend: Unable to evaluate BRNS's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
Hoog dividend: Unable to evaluate BRNS's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Winstuitkering aan aandeelhouders
Verdiendekking: Insufficient data to calculate BRNS's payout ratio to determine if its dividend payments are covered by earnings.
Contante uitbetaling aan aandeelhouders
Kasstroomdekking: Unable to calculate sustainability of dividends as BRNS has not reported any payouts.